Regeneron is public, listed as REGN on NASDAQ, in Healthcare and pharmaceuticals.
What it sells: Eylea, Dupixent.
In the language of this map it serves 2 solutions — Chronic-condition pharmaceuticals and Specialist medicine — which between them relieve 3 human frictions.
Its neighbourhood
Everything this entry connects to directly. Click any point to follow it.
Sells
Human frictions it ultimately relieves
Reached through the solutions above, never directly.